Ethics declarations Competing interests Through M.H.H.K., the VU University Medical Center has received research grants from AstraZeneca, Boehringer Ingelheim, Novo Nordisk and Sanofi
In clinical trials, participants who took the highest dose of the once-daily pill achieved an average weight loss of 12.4 percent, or 27.3 pounds, after 72 weeks, compared with 2.2 pounds with the placebo
Lead study author, Hamlet Gasoyan, DS, PhD, MPH, a researcher with Cleveland Clinics Center for Value-Based Care Research, spoke to Medical News Today , emphasizing the importance of these results in a real-world setting: Randomized clinical trials documented that discontinuation of novel obesity medications generally leads patients to regain weight, Gasoyan told us
Orforgliprons active ingredient is a nonpeptide small molecule that absorbs more readily in the gut without breaking down in the stomach
Your provider may recommend a different Nexa treatment such as GLP-1/GIP, LIPO-B, or Metformin or determine you're not eligible
Sleep Apnea: Causes breathing interruptions and fatigue, while increasing the risk of hypertension and heart disease